The impact of an infectious diseases consultation on antimicrobial prescribing

Joshua Osowicki¹, Amanda Gwee, Jesuina Noronha+13

• ¹Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital Melbourne, Parkville Department of Paediatric Infectious Diseases, Monash Children's, Clayton Department of Immunology and Infectious Diseases, Sydney Children's Hospital, Randwick, School of Women's and Children's Health, University of New South Wales, New South Wales Department of Infectious Diseases and Microbiology Pharmacy Department, The Children's Hospital at Westmead, Westmead, New South Wales Paediatric Infection Management Service, Mater Health Services, Department of Paediatrics, University of Queensland Mater Pharmacy Services, Mater Health, University of Queensland Centre for Clinical Research, South Brisbane Paediatric Infection Management Service, Mater Health Services, South Brisbane Infection Management and Prevention Service, Royal Children's Hospital, Brisbane, Queensland Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital for Children, Subiaco Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital for Children, Subiaco, School of Paediatrics and Children's Health, University of Western Australia, PathWest Laboratory Medicine WA, Princess Margaret Hospital, Western Australia SA Pathology, Women's and Children's Hospital, North Adelaide, South Australia Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital Melbourne, Murdoch Children's Research Institute, Parkville, Department of Paediatric Infectious Diseases, Monash Children's, Clayton, Australia, on behalf of the ANZPID-ASAP Group, Australian and New Zealand Paediatric Infectious Diseases, Australasian Stewardship of Antimicrobials in Paediatrics.